Illicit use of prescription adhd medications on a college campus: A multimethodological approach

Journal of American College Health

Volumn 57, Issue 3, 2008, Pages 315-324

  DeSantis, Alan ^a   Webb, Elizabeth M ^a   Noar, Seth M ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Adderall; ADHD; College students; Prescription drug abuse; Stimulants

Indexed keywords

AMPHETAMINE; AMPHETAMINE DERIVATIVE; CENTRAL STIMULANT AGENT; DEXAMPHETAMINE; DOPAMINE UPTAKE INHIBITOR; METHYLPHENIDATE;

ADOLESCENT; ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; DRUG ABUSE; FEMALE; HUMAN; INFORMATION PROCESSING; INTERVIEW; MALE; PILOT STUDY; QUALITATIVE RESEARCH; UNITED STATES;

ADOLESCENT; AMPHETAMINE-RELATED DISORDERS; AMPHETAMINES; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; DATA COLLECTION; DEXTROAMPHETAMINE; DOPAMINE UPTAKE INHIBITORS; FEMALE; HUMANS; INTERVIEWS AS TOPIC; MALE; METHYLPHENIDATE; PILOT PROJECTS; QUALITATIVE RESEARCH; UNITED STATES; YOUNG ADULT;

EID: 58149173175     PISSN: 07448481     EISSN: None     Source Type: Journal    
DOI: 10.3200/JACH.57.3.315-324     Document Type: Article

References (24)

1. McCabe SE, Teter CJ, Boyd CJ. The use, misuse and diversion of prescription stimulants among middle and high school students. Subst Use Misuse. 2004;39:1095-1116.
2. Olfson M, Marcus SC, Druss B, Pincus HA. National trends in the use of outpatient psychotherapy. Am J Psychiatry. 2002;159:1914-1920.
3. Robinson LM, Sclar DA, Skaer TL, Galin RS. National trends in the prevalence of attention-deficit/hyperactivity disorder and the prescribing of methylphenidate among school-age children: 1990-95. Clin Pediatr. 1999;38:209-217.
4. Rushton JL, Whitmire JT. Pediatric stimulant and selective serotonin reuptake inhibitor trends: 1992 to 1998. Arch Pediatr Med. 2001; 155:560-565.
5. Safer DJ, Zito JM, Fine EM. Increased methylphenidate usage for attention deficit disorder in the 1990s. Pediatrics. 1996;98: 1084-1088.
6. Centers for Disease Control and Prevention. Mental Health in the United States: prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder - United States, 2003. MMWR Morb Mortal Wkly Rep. 2005;54:842-847.
7. Woodworth T. DEA Congressional Testimony. Presented to: the Committee on Education and the Workforce: Subcommittee on Early Childhood, Youth and Families. May 16, 2000. http://www.dea.gov/pubs/cngrtest/ct051600.htm. Accessed June 21, 2007.
8. Babcock Q, Byrne T. Student perceptions of methylphenidate abuse at a public liberal arts college. J Am Coll Health. 2000;49:143-145.
9. Hall KM, Irwin MM, Bowman KA, Frakenberger W, Jewett DC. Illicit use of prescribed stimulant medication among college students. J of Am Coll Health. 2005;53:167-174.
10. Low KG, Gendaszek AE. Illicit use of psychostimulants among college students: a preliminary study. Psychol Health Med. 2002;7:283-287.
11. McCabe SE, Knight JR, Teter CJ, Wechsler H. Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey. Addiction. 2005;99:96-106.
12. McCabe SE, Teter CJ, Boyd CJ. Medical use, illicit use, and diversion of abusable prescription drugs. J Am Coll Health. 2006;54:269-278.
13. Shillington AM, Reed MB, Lange JE, Clapp JD, Henry S. College undergraduate Ritalin abusers in southwestern California: protective and risk factors. J Drug Issues. 2006;(Fall): 999-1014.
14. Teter CJ, McCabe SE, Cranford JA, Boyd CJ, Guthrie SK. Prevalence and motives for illicit use of prescription stimulants in an undergraduate student sample. J Am Coll Health. 2006;53:253-262.
15. Teter CJ, McCabe SE, LaGrange K, Cranford JA, Boyd CJ. Illicit use of specific prescription stimulants among college students: prevalence, motives, and routes of administration. Pharmacotherapy. 2006;26:1501-1510.
16. White BP, Becker-Blease KA, Grace-Bishop K. Stimulant medication use, misuse, and abuse in an undergraduate sample and graduate student sample. J Am Coll Health. 2006;54:261-268.
17. US Dept of Justice Drug Enforcement Administration. Section II: General Requirements. In: Practioner's Manual. http://www.deadiversion.usdoj.gov/pubs/ manuals/pract/section2.htm. Accessed July 30, 2007.
18. Centers for Disease Control and Prevention. Percent of Youth 4-17 Ever Diagnosed With Attention-Deficit/Hyperactivity Disorder: National Survey of Children's Health, 2003 [map], http://www.cdc.gov/ncbddd/adhd/ adhdprevalence.htm. Accessed June 1, 2007.
19. Pietrzak RH, Mollica CM, Maruff P, Snyder PJ. Cognitive effects of immediate-release methylphenidate in children with attention deficit/hyperactivity disorder. Neurosci Biobehav Rev. 2006;30:1225-1245.
20. Wilson HK, Cox DJ, Merkel RL, Moore M, Coghill D. Effect of extended release stimulant-based medications on neuropsychological functioning among adolescents with attention-deficit/hyperactivity disorder. Arch Clin Neuropsychol. 2006;21:797-807.
21. Hood J, Baird G, Rankin PM, Isaacs E. Immediate effects of methlyphenidate on cognitive attention skills of children with attention-deficit/hyperactivity disorder. Dev Med Child Neurol. 2005;47:408-414.
22. Mollica CM, Maruff P, Vance A. Development of a statistical approach to classifying treatment response in individual children with ADHD. Hum Psychopharmacol-Clin Exp. 2004;19:445-456.
23. Derzon JH, Lipsey MW. A meta-analysis of the effectiveness of mass communication for changing substance use knowledge, attitudes, and behavior. In: Crano WD, Burgoon M, eds. Mass Media and Drug Prevention: Classic and Contemporary Theories and Research. Mahwah, NJ: Erlbaum; 2002:231-258.
24. Noar SM. A 10-year retrospective of research in health mass media campaigns: where do we go from here? J Health Commun. 2006;11:21-42.